Condromed

Package Leaflet: Information for the Patient

CONDROMED 800 mg tablet

Sodium chondroitin sulfate

Read the package leaflet carefully before taking the medicine, as it contains important information for the patient.

• Keep this leaflet, you may need to read it again.
• In case of any doubts, consult a doctor or pharmacist.
• This medicine has been prescribed to a specific person. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. See section 4.

Table of Contents of the Leaflet

• 1. What is Condromed and what is it used for
• 2. Important information before taking Condromed
• 3. How to take Condromed
• 4. Possible side effects
• 5. How to store Condromed
• 6. Package contents and other information

1. What is Condromed and what is it used for

Condromed contains the active substance sodium chondroitin sulfate.
Condromed belongs to other non-steroidal anti-inflammatory and anti-rheumatic drugs.
It is indicated for the symptomatic treatment of knee osteoarthritis.
This medicine has a delayed effect, which may persist after treatment is stopped.

2. Important information before taking Condromed

When not to take Condromed

If the patient is allergic to sodium chondroitin sulfate or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Before starting to take Condromed, the patient should discuss it with their doctor or pharmacist if they have or have had liver, kidney, or heart disorders.

• if the patient currently has or has had liver, kidney, or heart disorders.

Children and adolescents

This medicine is not recommended for children and adolescents under 18 years of age.

Condromed and other medicines

The patient should tell their doctor or pharmacist about all medicines they are taking or have recently taken, as well as any medicines they plan to take, especially if they are taking anticoagulant medicines such as warfarin.

Condromed with food and drink

See section 3, "How to take Condromed".

Pregnancy, breastfeeding, and fertility

If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
This medicine is not recommended during pregnancy or breastfeeding.

Driving and using machines

Sodium chondroitin sulfate may have a minor effect on the ability to drive and use machines.
After taking the medicine, dizziness may occur (see section 4). If this happens, the patient should not drive or use machines.

Condromed contains sodium

The medicine contains 73 mg of sodium (the main component of common salt) per tablet, which corresponds to 3.8% of the maximum recommended daily intake of sodium in the diet for adults.

3. How to take Condromed

This medicine should always be taken exactly as prescribed by the doctor or pharmacist. In case of doubts, the patient should consult their doctor or pharmacist.
Adults
The recommended dose is one tablet per day.
Use in children and adolescents under 18 years of age
This medicine is not recommended for children and adolescents under 18 years of age.
Elderly patients and patients with kidney, liver, or heart disorders
Treatment of patients with kidney, liver, or heart disorders requires special caution (see "Warnings and precautions").
Instructions for use
The tablet can be taken before, during, or after a meal.

Overdose of Condromed

In case of overdose, the patient should immediately contact their doctor or go to the nearest hospital. They should take the medicine package with them.

Missed dose of Condromed

If a dose is missed, the patient should take it as soon as possible. However, if it is almost time for the next dose, they should not take the missed dose. They should not take a double dose to make up for the missed tablet.

Stopping Condromed treatment

In case of any further doubts about the use of this medicine, the patient should consult their doctor or pharmacist.

4. Possible side effects

Like all medicines, Condromed can cause side effects, although not everybody gets them.
Some side effects may be serious.
The following side effects have been reported with the following frequencies:
Rare(may affect up to 1 in 1000 people)

• Gastrointestinal disorders, such as abdominal pain, nausea, diarrhea
• Redness of the skin
• Rash

Very rare(may affect up to 1 in 10,000 people)

• Dizziness
• Hives
• Itching of the skin
• Rash
• Allergic reaction
• Swelling

Reporting side effects

If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Post-Marketing Surveillance of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: +48 22 49 21 301
fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
By reporting side effects, it is possible to gather more information on the safety of this medicine.

5. How to store Condromed

The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after: Expiry date (EXP). The expiry date refers to the last day of the month stated.
There are no special storage precautions for this medicine. Store in the original blister pack to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Package contents and other information

What Condromed contains

The active substance of Condromed is sodium chondroitin sulfate. Each tablet contains 800 mg of sodium chondroitin sulfate. The other ingredient is magnesium stearate.

What Condromed looks like and contents of the pack

It is a white or almost white, elongated, biconvex tablet with a diameter of about 21 mm.
The boxes contain 30 or 90 tablets.

Marketing authorization holder and manufacturer

Marketing authorization holder and manufacturer

IBSA Farmaceutici Italia srl
Via Martiri di Cefalonia 2
26900 Lodi
Italy
tel.: +48 22 653 68 60

Date of last revision of the leaflet: